
Imrecoxib vs. Celecoxib for Pain Control After Arthroscopic Knee Surgery
How to Cite
OrthoEvidence. Imrecoxib vs. Celecoxib for Pain Control After Arthroscopic Knee Surgery. ACE Report. 2022;271(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14814
Imrecoxib versus celecoxib as postoperative analgesia for patients receiving arthroscopic knee surgery: a randomized, controlled, non-inferiority study
Inflammopharmacology. 2022 Jun;30(3): 875-881.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and twenty-six patients undergoing arthroscopic knee surgery were randomized in this non-inferiority trial to receive either imrecoxib (n=64) or celecoxib (n=62). The primary outcome of interest pain scores on a Visual Analog Scale (VAS), measured at rest and during movement up to 72 hours post-operation. Secondary outcomes of interest included pethidine administration, patient satisfa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!


Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE
Please Login or Join to leave comments.